Core A: Administration and Bioanalysis Core
Core A: Administration and Bioanalysis Core
批准号:
8904707
负责人:
ROBERT TARRAN
金额:
$17.69万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-19 至 2016-06-30
关键词:
AdministratorAdvisory CommitteesAsthmaBioinformaticsBiologyBiometryBronchoalveolar LavageBudgetsCell Culture TechniquesChronic Obstructive Airway DiseaseCommunicationComputer AssistedContractsCystic FibrosisDoctor of PhilosophyEcologyEducational CurriculumElementsEnsureEnvironmental Engineering technologyEnvironmental MedicineEpithelial CellsFamilyFinancial ActivityGenesGoalsGrantGuidelinesHumanHuman ResourcesHuman RightsImmunologyIndividualInterdisciplinary StudyLeadershipLungManuscriptsMedicineMicrobiologyModelingMonitorNamesObstructive Lung DiseasesOutpatientsPathogenesisPatientsPediatricsPreparationPrincipal InvestigatorProblem SolvingProgress ReportsProtocols documentationPublicationsPulmonary Cystic FibrosisQuality ControlRecruitment ActivityResearchResearch PersonnelResourcesScheduleServicesSmokeSputumStudy SubjectSystemTNFRSF5 geneTestingTimeToxicologyTranslational ResearchUnited States National Institutes of HealthUniversitiesbasecostdesignexperiencehuman subjectmedical schoolsmeetingsmouse modelprofessorprogramssuccesstext searchingtobacco exposuretreatment center
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Administrative Core will provide (1) professional and (2) administrative functions to the Program ' Project.
1) Professional Component The professional component is designed to monitor the overall progress ofthe TCORS P50, solve problems as they arise, effect quality control, and provide direction for future research. Drs. Tarran and Doerschuk will provide this support to the Core. They will chair weekly meetings with Project and Core Leaders to ensure smooth, coordinated functioning of the projects and to develop new research directions. This function will be coordinated with meetings of the Advisory Committee. The Advisory Committee has been named and consists of:
1) David Peden, MD, Professor of Pediatrics, Medicine & Microbiology/ Immunology, Director ofthe UNC School of Medicine's Center for Environmental Medicine, Asthma and Lung Biology;
2) James Swenberg, PhD, Kenan Distinguished Professor of Environmental Sciences & Engineering; former Director ofthe Curriculum in Toxicology and
3) Richard Boucher, MD, Executive Associate Dean for Translational Research, Distinguished Professor of Medicine, Director of the Cystic Fibrosis/Pulmonary Research and Treatment Center and an expert on obstructive lung diseases.
In addition, Drs. Tarran and Doerschuk will chair a monthly administrative luncheon that is designed to monitor P50 personnel and budgetary matters and will monitor the Cores to ensure adequate support for the Projects. This Core will also be the interface with administrators of different departments and divisions within UNC as well as the University Office of Contracts and Grants.
2) Administrative Component
a. Budgetary and Programmatic Support:
The administrative component will provide the support services required to assure the smooth
functioning of each program element. These services will include the management of budget and personnel, and overseeing of communications, publication, and IT facilities. The goal of this facet of the Core will be to provide efficient administrative "resources to all P50~prdject and core investigators so that individual investigators' time for administrative matters will be minimized, permitting maximum time for research endeavors.
b. Human Subjects
The PSO obtains induced sputum, bronchoalveolar lavage and lower airways epithelial cells (Projects II and 2) and excised human lungs so that the Cell Culture Core (Core C) can provide P50 investigators with well-differentiated cell culture models. In addition, mouse models of smoke exposure will also be tested (Projects II and III). The Administrative Core will facilitate Human Rights Protocol and lACUC submission and compliance with all Federal/University guidelines for human research.
c. Personnel Dr. Tarran will be the P50 Principal Investigator and the Core Leader. He will be responsible for all scientific and administrative aspects ofthe P50. He has had administrative experience in leadership of NIH multidisciplinary research programs, including his serving as a Project Leader and Co-lnvestigator on a SCCOR on Airway Biology/Pathogenesis of Cystic Fibrosis and COPD (HL0849334) from 2006-2012 and a PPG from 2007-present (HL110873)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Peptide Fusion Inhibitors for the Treatment of COVID-19
-
批准号:10379832
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:ROBERT TARRAN
-
依托单位:
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung
-
批准号:10453601
-
项目类别:
-
资助金额:$98.82万
-
财政年份:2020
-
负责人:ROBERT TARRAN
-
依托单位:
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung
-
批准号:10404327
-
项目类别:
-
资助金额:$99.98万
-
财政年份:2020
-
负责人:ROBERT TARRAN
-
依托单位:
Do E-Cigarette Users Airways Have an Altered Lipid Content?
-
批准号:10037769
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2020
-
负责人:ROBERT TARRAN
-
依托单位:
Do E-Cigarette Users Airways Have an Altered Lipid Content?
-
批准号:10220134
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2020
-
负责人:ROBERT TARRAN
-
依托单位:
ELD607 Orai1 Antagonist Increases Bacterial Clearance from the Lung
-
批准号:10080273
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2020
-
负责人:ROBERT TARRAN
-
依托单位:
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd
-
批准号:8904703
-
项目类别:
-
资助金额:$60.99万
-
财政年份:2013
-
负责人:ROBERT TARRAN
-
依托单位:
The Impact of Tobacco Exposure on the Lungs Innate Defense System
-
批准号:8582362
-
项目类别:
-
资助金额:$400.0万
-
财政年份:2013
-
负责人:ROBERT TARRAN
-
依托单位:
The Impact of Tobacco Exposure on the Lungs Innate Defense System
-
批准号:9328114
-
项目类别:
-
资助金额:$400.0万
-
财政年份:2013
-
负责人:ROBERT TARRAN
-
依托单位:
The Impact of Tobacco Exposure on the Lungs Innate Defense System
-
批准号:8737945
-
项目类别:
-
资助金额:$400.0万
-
财政年份:2013
-
负责人:ROBERT TARRAN
-
依托单位:
The Impact of Tobacco Exposure on the Lungs Innate Defense System
-
批准号:8916361
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2013
-
负责人:ROBERT TARRAN
-
依托单位:
SPLUNC1-Derived Peptides as ENaC Antagonists
-
批准号:8645717
-
项目类别:
-
资助金额:$35.61万
-
财政年份:2012
-
负责人:ROBERT TARRAN
-
依托单位:
SPLUNC1-Derived Peptides as ENaC Antagonists
-
批准号:8295783
-
项目类别:
-
资助金额:$36.33万
-
财政年份:2012
-
负责人:ROBERT TARRAN
-
依托单位:
SPLUNC1-Derived Peptides as ENaC Antagonists
-
批准号:8468206
-
项目类别:
-
资助金额:$34.59万
-
财政年份:2012
-
负责人:ROBERT TARRAN
-
依托单位:
ASL volume and innate defense in CF and COPD Airways
-
批准号:7231807
-
项目类别:
-
资助金额:$33.19万
-
财政年份:2006
-
负责人:ROBERT TARRAN
-
依托单位:
Ion Transport and Mucus Clearance in CF Airways
-
批准号:7177545
-
项目类别:
-
资助金额:$20.77万
-
财政年份:2005
-
负责人:ROBERT TARRAN
-
依托单位:
Ion Transport and Mucus Clearance in CF Airways
-
批准号:7038269
-
项目类别:
-
资助金额:$21.39万
-
财政年份:2005
-
负责人:ROBERT TARRAN
-
依托单位:
Ion Transport and Mucus Clearance in CF Airways
-
批准号:6922179
-
项目类别:
-
资助金额:$24.81万
-
财政年份:2005
-
负责人:ROBERT TARRAN
-
依托单位:
ASL volume and innate defense in CF and COPD Airways
-
批准号:8115819
-
项目类别:
-
资助金额:$49.75万
-
财政年份:--
-
负责人:ROBERT TARRAN
-
依托单位:
Project 1: The Effects of New and Emerging Tobacco Products on Lung Hyd
-
批准号:8595536
-
项目类别:
-
资助金额:$70.99万
-
财政年份:--
-
负责人:ROBERT TARRAN
-
依托单位:
海外基金